美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SATELLOS BIOSCIENCE INC.

7.30

+0.27003.84%

盤後：7.300.00000.00%17:10 EDT

成交量：4.74萬

成交額：33.80萬

市值：1.52億

市盈率：-4.03

高：7.45

開：6.99

低：6.82

收：7.03

52周最高：13.39

52周最低：5.50

股本：2,083.12萬

流通股本：1,751.03萬

量比：2.11

換手率：0.27%

股息：- -

股息率：- -

每股收益(TTM):-1.8136

每股收益(LYR):-1.7041

淨資產收益率：-50.74%

總資產收益率：-31.38%

市淨率：2.15

市盈率(LYR):-4.28

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

SATELLOS BIOSCIENCE INC.

交易所：

NASDAQ

成立時間：

2018

員工人數：

20

公司地址：

Royal Bank Plaza,Suite 2800,South Tower,200 Bay Street,Toronto,Ontario,Canada

官網：

http://www.satellos.com;ir.satellos.com

郵編：

M5J 2J1

電話：

- -

傳真：

- -

簡介：

Satellos Bioscience Inc.於2006年4月20日根據《商業公司法》（不列顛哥倫比亞省）註冊成立。該公司是一家臨床階段的藥物開發公司，致力於開發退行性肌肉疾病的治療方法。其主要候選藥物SAT-3247是一種口服小分子，旨在恢復杜氏肌營養不良症等情況下的骨骼肌再生。該候選藥物目前正在兩項名為BASECAMP和TRAILHEAD的試驗中進行臨床評估。該公司繼續利用其專有的MyoReGenX平台來確定退行性肌肉疾病的額外治療機會。

董事

名稱

職位

Frank Gleeson

Chief Executive Officer and Director and President

Geoff MacKay

Chairman and Director

Adam Mostafa

Director

Brian Bloom

Director

Franklin Berger

Director

Iris Loew Friedrich

Director

Mark Nawacki

Director

Selwyn Ho

Director

Stephanie Brown

Director

股東

名稱

職位

Frank Gleeson

Chief Executive Officer and Director and President

Elizabeth Williams

Chief Financial Officer

Michael Rudnicki

Chief Discovery Officer

Phil Lambert

Chief Scientific Officer

Wildon Farwell

Chief Medical Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MSLE/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MSLE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSLE\",,,,,undefined,":{"symbol":"MSLE","market":"US","secType":"STK","nameCN":"SATELLOS BIOSCIENCE INC.","latestPrice":7.3,"timestamp":1780084800000,"preClose":7.03,"halted":0,"volume":47432,"hourTrading":{"tag":"盘后","latestPrice":7.3,"preClose":7.3,"latestTime":"17:10 EDT","volume":703,"amount":5146.9451,"timestamp":1780089022410,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03840682788051203,"floatShares":17510300,"shares":20831190,"eps":-1.813562,"marketStatus":"休市中","change":0.27,"latestTime":"05-29 16:00:00 EDT","open":6.99,"high":7.4499,"low":6.82,"amount":337983.973096,"amplitude":0.089602,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.813562,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1780300800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":7.03,"postHourTrading":{"tag":"盘后","latestPrice":7.3,"preClose":7.3,"latestTime":"17:10 EDT","volume":703,"amount":5146.9451,"timestamp":1780089022410,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.1105840523107635},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSLE\",,,,,undefined,":{"symbol":"MSLE","floatShares":17510300,"roa":"-31.38%","roe":"-50.74%","lyrEps":-1.704123,"volumeRatio":2.1105840523107635,"shares":20831190,"dividePrice":0,"high":7.4499,"amplitude":0.089602,"preClose":7.03,"low":6.82,"week52Low":5.5,"pbRate":"2.15","week52High":13.3949,"institutionHeld":0,"latestPrice":7.3,"eps":-1.813562,"divideRate":0,"volume":47432,"delay":0,"ttmEps":-1.813562,"open":6.99,"prevYearClose":12.5,"prevWeekClose":6.75,"prevMonthClose":7.95,"prevQuarterClose":5.63,"fiveDayClose":7.14,"twentyDayClose":7.95,"sixtyDayClose":12.27},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSLE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-15","symbol":"MSLE","fiscalQuarterEnding":"2026/03","expectedEps":-0.51,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2026-03-27","symbol":"MSLE","fiscalQuarterEnding":"2025/12","expectedEps":-0.36,"name":null,"time":"盤前","type":"earning","dateTimestamp":1774584000000,"reportTimeType":"pre","actualEps":-0.47},{"market":"US","date":"2026-02-06","symbol":"MSLE","reason":null,"defaultRemindTime":1770388200000,"announcedDate":"2026-02-05","type":"delisting","dateTimestamp":1770354000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSLE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MSLE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1779336000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MSLE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MSLE","date":"2026-05-29","current":-4.025228,"percent":0.868421,"low":-12.479818,"twenty":-10.770158,"median":-6.614029,"eighty":-5.255741,"high":-4.777882,"avg":-7.549182,"sd":2.409533,"marketCap":145462670.32},"quantilePoints":[{"date":"2026-02-13","current":-10.770362,"twenty":-10.948162,"median":-10.770362,"eighty":-10.650272,"marketCap":232264709.51},{"date":"2026-02-20","current":-10.655876,"twenty":-10.961105,"median":-10.795625,"eighty":-10.660269,"marketCap":229795787.77},{"date":"2026-02-27","current":-11.410036,"twenty":-11.040635,"median":-10.847134,"eighty":-10.698718,"marketCap":246059372.56},{"date":"2026-03-06","current":-11.830077,"twenty":-11.717077,"median":-10.918938,"eighty":-10.750564,"marketCap":255117626.85},{"date":"2026-03-13","current":-8.109914,"twenty":-11.50908,"median":-10.908981,"eighty":-10.660269,"marketCap":174891683.43},{"date":"2026-03-20","current":-7.707011,"twenty":-11.414276,"median":-10.795625,"eighty":-8.641353,"marketCap":166203013.02},{"date":"2026-03-27","current":-6.631132,"twenty":-11.347113,"median":-10.74587,"eighty":-7.112164,"marketCap":143001488.38},{"date":"2026-04-02","current":-5.025579,"twenty":-11.228066,"median":-10.659537,"eighty":-6.857362,"marketCap":125001211.63},{"date":"2026-04-10","current":-5.215911,"twenty":-11.093473,"median":-9.47912,"eighty":-5.796539,"marketCap":129735363.26},{"date":"2026-04-17","current":-7.29856,"twenty":-11.048776,"median":-7.908462,"eighty":-5.702641,"marketCap":181537079.31},{"date":"2026-04-24","current":-5.815307,"twenty":-10.982188,"median":-7.307008,"eighty":-5.899657,"marketCap":144644124.23},{"date":"2026-05-01","current":-6.614029,"twenty":-10.910972,"median":-7.101939,"eighty":-6.007657,"marketCap":164510727.14},{"date":"2026-05-08","current":-6.017774,"twenty":-10.898871,"median":-6.946772,"eighty":-6.020777,"marketCap":149680075.96},{"date":"2026-05-15","current":-6.08008,"twenty":-10.857436,"median":-6.796189,"eighty":-6.025643,"marketCap":151229840.1},{"date":"2026-05-22","current":-5.211571,"twenty":-10.78552,"median":-6.687256,"eighty":-5.618291,"marketCap":148529791.46},{"date":"2026-05-29","current":-5.103954,"twenty":-10.770158,"median":-6.614029,"eighty":-5.255741,"marketCap":145462670.32}],"updateTime":1780130702966},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":650365067,"yearFounded":2018,"employeeNum":20,"address":"Royal Bank Plaza,Suite 2800,South Tower,200 Bay Street,Toronto,Ontario,Canada","zipCode":"M5J 2J1","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.satellos.com;ir.satellos.com","stockEarnings":[{"period":"1week","weight":-0.0154},{"period":"1month","weight":-0.0762},{"period":"3month","weight":-0.4308},{"period":"6month","weight":-0.4376},{"period":"ytd","weight":-0.4376}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0603},{"period":"3month","weight":0.1},{"period":"6month","weight":0.1042},{"period":"1year","weight":0.2839},{"period":"ytd","weight":0.1066}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Satellos Bioscience Inc.於2006年4月20日根據《商業公司法》（不列顛哥倫比亞省）註冊成立。該公司是一家臨床階段的藥物開發公司，致力於開發退行性肌肉疾病的治療方法。其主要候選藥物SAT-3247是一種口服小分子，旨在恢復杜氏肌營養不良症等情況下的骨骼肌再生。該候選藥物目前正在兩項名為BASECAMP和TRAILHEAD的試驗中進行臨床評估。該公司繼續利用其專有的MyoReGenX平台來確定退行性肌肉疾病的額外治療機會。","exchange":"NASDAQ","name":"SATELLOS BIOSCIENCE INC.","nameEN":"SATELLOS BIOSCIENCE INC."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MSLE\",market:\"US\",,,undefined,":{"directors":[{"name":"Frank Gleeson","position":"Chief Executive Officer and Director and President"},{"name":"Geoff MacKay","position":"Chairman and Director"},{"name":"Adam Mostafa","position":"Director"},{"name":"Brian Bloom","position":"Director"},{"name":"Franklin Berger","position":"Director"},{"name":"Iris Loew Friedrich","position":"Director"},{"name":"Mark Nawacki","position":"Director"},{"name":"Selwyn Ho","position":"Director"},{"name":"Stephanie Brown","position":"Director"}],"executives":[{"name":"Frank Gleeson","position":"Chief Executive Officer and Director and President"},{"name":"Elizabeth Williams","position":"Chief Financial Officer"},{"name":"Michael Rudnicki","position":"Chief Discovery Officer"},{"name":"Phil Lambert","position":"Chief Scientific Officer"},{"name":"Wildon Farwell","position":"Chief Medical Officer"}]}}}